132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$177.2B
P/E ttm
22.8
Fwd P/E
14.0
Beta
0.43
Day range
$328.26
52w range
$312.39 – $391.29
Avg vol
2.6M
RSI(2)
4.5
ROE
101.3%
Net mgn
21.0%
FCF mgn
20.0%
Debt/Eq
6.24
Div yld
306.00%
Sector
Healthcare
Industry
Drug Manufacturers - General
Next earn
2026-08-04
Matrix setup grades
Long
—
score 17 · tech 17 / 80 · support 0 / 20
KC1 lower, -0.82 ATR from EMA21 · no notable pattern
- · KC1 lower stretch — light dip
Short
—
score 12 · tech 12 / 80 · support 0 / 20
below KC1 upper, -0.82 ATR from EMA21 · no notable pattern
- · Aligned with weak downtrend
Options · swing
See more →
CALL
$330
2026-07-17
$11.28
PUT
$325
2026-07-17
$9.43
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-04-30
- EPS (act / est)
- 5.15 / 4.77
- Surprise
- +8.0%
- Next report
- 2026-08-04
About
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat post…